ArticleAnnals of translational medicine2021

TP53 and CDKN2A mutations in patients with early-stage lung squamous cell carcinoma: an analysis of the correlations and prognostic outcomes.

Peiyuan Wang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.